Rheumatoid arthritis that was resistant to methotrexate and sulfasalazine developed in a 25-
year-old woman who was evaluated for possible treatment with a tumor necrosis factor …

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the
treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness …

Abstract Models for the economic evaluation of health technologies provide valuable
information to decision makers. The choice of model structure is rarely discussed in …

Background Rheumatoid arthritis (RA) is a common inflammatory condition that typically
causes a symmetrical chronic arthritis that causes joint pain, swelling and in some cases a …

OBJECTIVES: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with
increasing disability, reduced quality of life and substantial costs (as a result of both …

Objective Measurement of physical function at one point in time cannot distinguish
impairment caused by the active disease process from chronic irreversible impairment. We …

OBJECTIVES: To evaluate the clinical effectiveness, safety, tolerability and cost-
effectiveness of etanercept and efalizumab for the treatment of moderate to severe chronic …

Objective To review the cost effectiveness of rheumatoid arthritis (RA) treatments and inform
the clinical recommendations by the European League Against Rheumatism. Methods A …

Background and Objectives Economic evaluations provide information to aid the optimal
utilization of limited healthcare resources. Costs of biologics for Rheumatoid arthritis (RA) …

Книга посвящена биологической терапии, являющейся наиболее успешным и
перспективным направлением в лечении ревматических заболеваний. Авторы …